Kyongbo Pharmaceutical Co., Ltd (214390.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 137.75B |
| Enterprise Value | 257.19B |
| P/E Ratio | 478.83 |
| PEG Ratio | -5.38 |
| Price/Sales Ratio | 0.45 |
| Price/Book Ratio | 0.84 |
| Enterprise/Revenue | 0.96 |
| Enterprise/EBITDA | 14.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0 |
Income Statement
| Revenue | 264.1B |
| Revenue/Share | 11,278.82 |
| Gross Profit | 97.82B |
| EBITDA | 16.72B |
| Net Income | 182.29M |
| Diluted EPS | 7.63 |
Balance Sheet
| Total Cash | 9.95B |
| Total Cash/Share | 416.23 |
| Total Debt | 143.03B |
| Total Debt/Equity | 0.99 |
| Current Ratio | 0.94 |
| Book Value Per Share | 6,035.54 |
Price History
| 52-Week Change | -0.39 |
| 52-Week High | 9,300 |
| 52-Week Low | 4,700 |
| Moving Average 50 Days | 5,328.2 |
| Moving Average 200 Days | 5,993.8 |
Statistics
| Average Volume | 58,997 |
| Shares Outstanding | 23.91M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 50 |
| Trailing Annual Dividend Yield | 0.98 |
| Payout Ratio | 4.58 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
